OR WAIT null SECS
DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced a new partnership with Argentinian CRO STAT Research. STAT Research provides a full range of research services in the Latin American region.
STAT Research CEO Dr. Conrado J. Estol stated: “In the context of a rapidly expanding clinical trial field in the early 2000’s, we saw the opportunity to develop a company to become leaders based on our previous research expertise developed over many years in the USA. Our initial focus on CNS soon spanned into many other medical specialties and our group grew solid by incorporating some of the people with most clinical trial experience in the region. Our recent partnership with DATATRAK will add the necessary tools to achieve much more effective and efficient results in an increasingly complex and time-sensitive research environment”.
“Our partnership with STAT Research combines the DATATRAK ONE™ technology with local industry experts to create a superior solution for advancing clinical trials in Latin America,” stated Laurence P. Birch, DATATRAK’s Chairman of the Board and CEO. “We look forward to assisting STAT Research in leveraging the DATATRAK ONE™ clinical research platform to reduce clinical trial costs and accelerate drug development timelines.”
The DATATRAK Connect™ Partner Program is collaboration between synergic companies to accelerate the drug development process. The program allows for extended service offerings to cover all areas of the drug development process with the goal of reducing study costs and furthering business development objectives.